Diffuse panbronchiolitis after humanized anti-CCR4 monoclonal antibody therapy for relapsed adult T-cell leukemia/lymphoma

International Journal of Hematology

Volumn 97, Issue 3, 2013, Pages 430-432

  Kato, Koji ^a   Miyamoto, Toshihiro ^a   Numata, Akihiko ^a   Nakaike, Takashi ^a   Oka, Hideyo ^a   Yurino, Ayano ^a   Kuriyama, Takuro ^a   Mori, Yasuo ^a   Yamasaki, Satoshi ^a   Muta, Tsuyoshi ^a   Takenaka, Katsuto ^a   Iwasaki, Hiromi ^b   Teshima, Takanori ^b   Akashi, Koichi ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Adult t cell leukemia lymphoma; Diffuse panbronchiolitis; Humanized anti ccr4 monoclonal antibody

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CYCLOPHOSPHAMIDE; DOXORUBICIN; MITOXANTRONE; MOGAMULIZUMAB; PREDNISOLONE; RANIMUSTINE; VINCRISTINE; CCR4 PROTEIN, HUMAN; MONOCLONAL ANTIBODY;

ADULT; ARTERIAL GAS; ARTICLE; BRONCHIOLITIS; CASE REPORT; DIFFUSE PANBRONCHIOLITIS; DYSPNEA; FEMALE; FOLLOW UP; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; JAPANESE; LEUKOCYTE COUNT; LUNG LAVAGE; OXYGEN SATURATION; OXYGEN THERAPY; PHYSICIAN; RASH; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE; ANOXIA; CHEMICALLY INDUCED DISORDER; HAEMOPHILUS INFECTION; MIDDLE AGED; PATHOLOGY; TIME;

ANOXIA; ANTIBODIES, MONOCLONAL, HUMANIZED; BRONCHIOLITIS; FEMALE; HAEMOPHILUS INFECTIONS; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MIDDLE AGED; RECEPTORS, CCR4; TIME FACTORS;

EID: 84887734755     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-013-1278-z     Document Type: Article

References (16)

1. Ishida T, Joh T, Uike N, et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: A multicenter phase II study. J Clin Oncol. 2012;30:837-42.
2. Tsukasaki K, Hermine O, Bazarbachi A, et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: A proposal from an international consensus meeting. J Clin Oncol. 2009;27:453-9.
3. Yamashiro T, Kamiya H, Miyara T, et al. CT scans of the chest in carriers of human T-cell lymphotropic virus type 1: presence of interstitial pneumonia. Acad Radiol. 2012;19:952-7.
4. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481-92.
5. Tsukasaki K, Utsunomiya A, Fukuda H, et al. VCAP-AMPVECP compared with biweekly CHOP for adult T-cell leukemialymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol. 2007;25:5458-64.
6. Yamamoto K, Utsunomiya A, Tobinai K, et al. Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol. 2010;28:1591-8.
7. Ishida T, Ishii T, Inagaki A, et al. Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege. Cancer Res. 2006;66: 5716-22.
8. Sugimoto M, Kitaichi M, Ikeda A, Nagai S, Izumi T. Chronic bronchioloalveolitis associated with human T-cell lymphotrophic virus type I infection. Curr Opin Pulm Med. 1998;4:98-102.
9. Ono K, Shimamoto Y, Matsuzaki M, et al. Diffuse panbronchiolitis as a pulmonary complication in patients with adult T-cell leukemia. Am J Hematol. 1989;30:86-90.
10. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986;1:1031-2.
11. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985;2:407-10.
12. Mochizuki M, Watanabe T, Yamaguchi K, et al. Uveitis associated with human T lymphotropic virus type I: seroepidemiologic, clinical, and virologic studies. J Infect Dis. 1992;166:943-4.
13. Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet. 1989;1:441.
14. Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S. Circulating CD8 cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature. 1990;348:245-8.
15. Kadota J, Mukae H, Tomono K, Kohno S. High concentrations of beta-chemokines in BAL fluid of patients with diffuse panbronchiolitis. Chest. 2001;120:602-7.
16. Poletti V, Casoni G, Chilosi M, Zompatori M. Diffuse panbronchiolitis. Eur Respir J. 2006;28:862-71.